Create Visual Guides for Faster Rare Diagnoses

Your early support has helped us continue our work of turning complex rare disease knowledge into visual, patient-centered education that families and clinicians can understand, share, and use. We are excited to share the significant progress we have made in the last three months through a combination of grassroots support and strategic partnerships.

1. High-Impact Visual Guides: Already Reaching Thousands

We have successfully completed two major diagnostic visual guides:

• Primary Fanconi Syndrome (PFS): This guide is already live! We are incredibly proud to share that it has reached over 26,000 views online. This confirms the massive demand for accessible, visual medical knowledge.

• Immune Thrombotic Thrombocytopenic Purpura (iTTP): This guide is finalized and ready for release.

  • Transparency Note: To ensure we keep moving even while fundraising, the production of the iTTP guide was made possible through support from a CSR (Corporate Social Responsibility) partner. This collaboration allows us to tackle high-need areas quickly while keeping our core content free for the community.

• The Pipeline: We are now self-funding the production of two rare conditions—Emery-Dreifuss Muscular Dystrophy and Danon Disease.

2. Innovation: Testing Our Rare Disease AI Assistant

We believe technology can scale our impact. We are currently pilot-testing an AI-powered Knowledge Base.

• We are transforming the rigorous clinical research from our visual guides into an interactive AI tool.

• This allows patients and doctors to ask specific questions and receive evidence-based answers instantly. Your donations on GlobalGiving are crucial for the R&D of these digital tools that no single corporate partner typically covers.

3. Education: Training the Next Generation

Our Training Course for medical students and patient leaders is now in the curriculum planning phase. We are designing the modules to ensure that "early recognition" becomes a standard skill for future clinicians.

Why Your Individual Donation Matters

You might wonder: If you have corporate partners, why do you need my $10 or $50?

The answer is simple: Corporate funding often focuses on specific diseases with existing treatments. However, there are thousands of "ultra-rare" diseases that have no commercial interest.

• Your donations allow us to remain independent and create guides for the "orphans among orphans"—the diseases that would otherwise be left in the dark.

• Your support funds the distribution of these materials to remote, grassroots clinics that corporate programs rarely reach.

We are deeply grateful to our first 3 donors. You are the reason we can stay committed to every rare disease family, not just those with industry visibility.

With gratitude,

The Wonder Sir & Canbaoer Team

Links:

• A Guide for Primary Fanconi Syndrome in Chinese